News Release

Higher vitamin D doses may be needed to restore healthy levels in overweight blacks

Peer-Reviewed Publication

Medical College of Georgia at Augusta University

Dr. Yanbin Dong, Medical College of Georgia at Georgia Regents University

image: Dr. Yanbin Dong is a geneticist and cardiologist at the Georgia Prevention Institute at the Medical College of Georgia at Georgia Regents University. view more 

Credit: Phil Jones

AUGUSTA, Ga. -The current recommended minimum daily dose of vitamin D is not sufficient to restore healthy vitamin D levels in overweight or obese blacks, researchers report.

Rather, daily intake of more than three times the recommended minimum is needed to restore what is generally considered a healthy blood level of vitamin D, said Dr. Yanbin Dong, geneticist and cardiologist at the Georgia Prevention Institute at the Medical College of Georgia at Georgia Regents University.

Overweight blacks are at increased risk for vitamin D deficiency because darker skin absorbs less sunlight - the skin makes vitamin D in response to sun exposure - and fat tends to sequester vitamin D for no apparent purpose.

The study, published in the journal BioMed Central Obesity, looked at the effects of three levels of vitamin D supplementation in 70 overweight-to-obese blacks under age 50 living in the Southeastern United States who appeared healthy, although their circulating level of vitamin D was considered low.

The Institute of Medicine recommends a daily intake of 600 international units of vitamin D for most children and adults; 800 IUs for those age 70 and older. For adolescents and adults, they recommend 4,000 IUs as the upper daily limit; 2,000 was the previous upper limit.

In what appears to be the first randomized controlled study in this cohort, researchers found that 600 IUs did not restore what many experts consider the optimal blood level of vitamin D within 16 weeks.

However, both 2,000 and 4,000 IUs restored the desirable levels of 30 nanograms per milliliter to individuals with previous levels of less than 20 ng/mL, levels which put them at high risk for bone-weakening rickets and potentially other maladies.

The 4,000 upper-limit dose restored the healthy blood level quicker - by eight weeks - and was also better at suppressing parathyroid hormone, which works against vitamin D's efforts to improve bone health by absorbing calcium, said Dong, the study's corresponding author.

"We hope these studies will give physicians better guidelines for some of their patients," said Dong. "As with many therapies in medicine today, evidence is emerging that a more personalized approach is likely the best approach when determining how much vitamin D is optimal for an individual. Dose definitely matters."

As an example, participants in the group he studied who had high parathyroid hormone levels likely should take 4,000 IUs daily while the remainder appear to achieve desired results with 2,000 IUs.

Although long known as a way to build strong bones and teeth, there is increasing evidence of vitamin D's role in the cardiovascular and immune systems, kidneys, mental health, and more. It's likely, as with high parathyroid hormone levels, patients at high risk for cardiovascular disease might benefit from higher doses, said Dong, noting that much work is needed to identify optimal dosing for specific conditions.

Although wide ranges of daily doses already have been studied and there are no known serious side effects, there is no point in people taking more than they should, even if it's only to save money, Dong said. Also, correlations are emerging - but no hard science yet - that at too-high doses, for example, vitamin D can go from being a cancer preventer to a cause, he said.

For the study, researchers gave all doses of vitamin D monthly rather than daily to help ensure that all participants were getting the correct doses. Giving this once-monthly version of even the maximum recommended daily dose was equivalent to spending an afternoon at the beach in a bathing suit, Dong said.

###

Dr. Jigar Bhagatwala, a research resident in the MCG Department of Medicine, is the study's first author. The research was funded by the National Institutes of Health and the American Heart Association.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.